Engineering and platform development
Research-led hardware, process and application development grounded in the technology’s Newcastle University origins.
Evidence
JetBio is moving from funded research and university deployments towards commercial validation. This page separates what is demonstrated today from what must still be proven for a repeatable product.

Research deployment programme
The 3D-IV programme, backed by NC3Rs, supports development and application testing with Newcastle, Bristol and Cambridge universities.
Research-led hardware, process and application development grounded in the technology’s Newcastle University origins.
A research deployment used to gather scientific and operational feedback for in vitro model development.
Collaborative research contributing to user requirements, application development and product definition.
Current status These are research deployments and application-development activities, not commercial sales.

Technology foundations
JetBio was established to commercialise ReJI bioprinting technology developed through Newcastle University research. Detailed IP status is provided through controlled technical and investor diligence.
The commercial task now is to turn technical potential into documented, repeatable workflows with clear performance claims, specifications, support and buyer value.
Peer-reviewed foundations
JetBio now brings the ReJI research record into one publication library, with DOI links and plain-language summaries of what each paper studied.
Evidence boundary
Letters of interest and research collaborations indicate demand and relevance. They are not represented as orders, revenue or completed commercial sales.
See the commercialisation caseStart a useful conversation
A useful feasibility project starts with the decision criteria, not the demonstration. Tell us what proof would make JetBio credible in your workflow.